Each winter, colds and flu put millions of people out of commission. Unless you live in a bubble, you’ll be exposed to viruses. Minimizing your risk of infection or knowing what to take to beat unwanted bugs is essential.

While there are many effective prevention strategies, the most important of all is maintaining a strong immune system. That way, your body will fight off an infection before it gets out of control and makes you sick.

Perhaps the most popular immune-modulator is Echinacea Purpurea. But with so many Echinacea products on the market how do you know you are getting the best one for either prevention or treatment.

The answer lies within the clinical backing, freshness and quality of the product.

Our Key Research
A.Vogel’s Echinaforce® line of products has over 20 published studies under its belt including the largest clinical study on Echinacea purpurea in history, done in 2012 by Scientists at the Common Cold Centre at Cardiff University. The study proved that Echinaforce® can be taken daily for up to four months to significantly reduce chances of catching a virus by over 50%.

In 2015, another double blind placebo controlled study went further, showing Echinaforce® Hot Drink to be as effective as Oseltamivir (Tamiflu), the gold standard antiviral prescription medication, used to block the actions of influenza virus types A and B in your body.

Echinaforce® Hot Drink outperformed Oseltamivir in measures of risk of complications and safety and side effects. In the Oseltamivir group, pneumonia, sinusitis, bronchitis and other complications occurred at a higher rate compared to the Echinaforce® Hot Drink group.

Unlike Oseltamivir, Echinaforce® Hot Drink’s availability as an over-the- counter medicine makes it an optimal treatment for influenza at the earliest onset of symptoms, which is a key factor when treating this common viral infection. It also does not cause rebound effects on discontinuation and does not lose effectiveness when taken repeatedly.

The Fresh Factor
Alfred Vogel discovered at an early age that the strength and therapeutic potential are at their zenith in fresh plants. His theory was that preparations made of fresh plants contain a significant higher concentration of active ingredients than dried plant extract. His theory was supported by his observations, interviews with patients and by clinical research published in 1994. His studies on the fresh, organic, GMO free Echinacea used in Echinaforce® proved to be 10 x more effective.

This is why all A.Vogel remedies are as fresh as nature. Plants for the manufacture of A.Vogel products are used within a maximum of 24 hours after harvest.

The Echinaforce® line (excluding the Sore Throat Spray) is the only product backed by Health Canada that can be used by pregnant or nursing women and by children ages 2+.


1. Sharma M, Anderson SA, Schoop R, Hudson JB: Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res. 2009 Aug; 83(2):165-70

2. Sharma M, Schoop R, Hudson JB: Echinacea as an anti-inflammatory agent: the influence of physiologically relevant parameters. Phytother Res. 2009 Jun;23(6):863-7.
3. Sharma M, Anderson M, Schoop R, Hudson JB: Bactericidal and anti-inflammatory properties of a standardized Echinacea extract: Dual actions against respiratory bacteria. Phytomedicine. 2010 July; 17(8-9): 563-8.
4. Ritchie MR, et al. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells. Phytomedicine 2011;18(10):826-31. Schoop R, et al.
5. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther. 2006;28(2):174-83.
6. Shah SA, et al. Evaluation of Echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007;7(7):473-80.
7. Brinkeborn R, et al. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold: A randomized, placebo controlled, double-blind clinical trial. Phytomedicine. 199;6(1):1-6.
8. Schapowal A, Klein P, Johnston SL. Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials. Adv Ther. 2015;32(3):187-200.
9. Raus K, Schoop R, Pleschka S, Klein P, Fisher P. Echinaforce Hotdrink versus Oseltamivir in influenza: A randomized, double-blind,double-dummy, multicenter, non-inferiority clinical trial. Curr Ther Res 2015; Publication stage: In Press Accepted Manuscript.